Key statistics
As of last trade Axsome Therapeutics Inc (19X:MUN) traded at 93.12, -2.67% below its 52-week high of 95.67, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 93.12 |
---|---|
High | 93.12 |
Low | 93.12 |
Bid | 94.08 |
Offer | 95.46 |
Previous close | 94.21 |
Average volume | 639.89 |
---|---|
Shares outstanding | 48.00m |
Free float | 39.17m |
P/E (TTM) | -- |
Market cap | 4.71bn USD |
EPS (TTM) | -6.54 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 07:00 GMT.
More ▼
Announcements
- Axsome Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
- Axsome Therapeutics Presents Data from Its Leading Neuroscience Pipeline at NEI Congress 2024
- Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
- Axsome Therapeutics to Report Third Quarter 2024 Financial Results on November 12
- Axsome Therapeutics Presents Data from Multiple Programs at Sleep Europe 2024
- Axsome Therapeutics Announces FDA Acceptance of NDA Resubmission for AXS-07 for the Acute Treatment of Migraine
- Axsome Therapeutics to Participate in Investor Conferences in September
- Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.
- Axsome Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Axsome Therapeutics to Report Second Quarter 2024 Financial Results on August 5
More ▼